NAC has therapeutic potential in treating neuropsychiatric diseases as an adjunctive treatment for disorders like obsessive-compulsive and related disorders, autism, major depression, bipolar depression, and schizophrenia [152]
Contribuye a la salud cardiovascular: Ayuda al metabolismo de las grasas, lo que puede apoyar niveles saludables de colesterol
What Clinical Trials Reveal About Tirzepatide and Mood The SURMOUNT-4 trial and other major studies tracking tirzepatide found that depression and anxiety each occurred in fewer than 2% of participants at treatment-ending doses
Furthermore, emerging tools such as in silico methodologies (105), and the Nutraceutical Interaction Risk Score (NIRS) (106), offer valuable resources for clinicians
In this context, the direct effects of DPP4 inhibitors require to be assessed in more detail, and several aspects like the cardio-protective function of DPP4 inhibition remains controversial